China’s weight loss drugs market could grow to US$5.6 billion by 2035, according to Goldman Sachs
The companies will collaborate on supply chain and sales channel development ahead of Innovent’s launch of mazdutide, as well as engage in a consumer education campaign.
“Innovent and JD Health will join hands to popularise knowledge about weight loss and blood sugar control via on and offline channels,” Innovent said in a statement posted on its WeChat account on Tuesday.
No comments:
Post a Comment